Enfortumab Vedotin in Advanced Urothelial Carcinoma
- PMID: 34192440
- DOI: 10.1056/NEJMc2106975
Enfortumab Vedotin in Advanced Urothelial Carcinoma
Comment in
-
Enfortumab Vedotin in Advanced Urothelial Carcinoma. Reply.N Engl J Med. 2021 Jul 1;385(1):93-94. doi: 10.1056/NEJMc2106975. N Engl J Med. 2021. PMID: 34192441 No abstract available.
Comment on
-
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma.N Engl J Med. 2021 Mar 25;384(12):1125-1135. doi: 10.1056/NEJMoa2035807. Epub 2021 Feb 12. N Engl J Med. 2021. PMID: 33577729 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical